BDK-IN-1
Product Specifications
Target
Endogenous Metabolite, EGFR, Apoptosis, VEGFR
Related Pathways
Apoptosis, Metabolism, Angiogenesis, JAK/STAT signaling, Tyrosine Kinase/Adaptors
Bioactivity
BDK-IN-1 (compound (-) -43) is a BDK inhibitor with an IC50 of 0.23 μM and a maximum inhibition rate of 90%. It reduces phosphorylated-E1 levels and is useful in the study of cardiac metabolic diseases.
Molecular Formula
C18H14F2N2O3S
Molecular Weight
376.38
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
